BCB BANCORP INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BCB BANCORP INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($12.53M) | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $18.62M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $29.48M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $45.58M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $34.24M | Mar 8, 2024 |
| FY2020 | Dec 31, 2020 | $7.30M | Mar 10, 2021 |
| FY2020 | Sep 30, 2020 | $8.31M | Mar 10, 2021 |
| FY2020 | Jun 30, 2020 | $2.73M | Mar 10, 2021 |
| FY2020 | Mar 31, 2020 | $2.52M | Mar 10, 2021 |
| FY2020 | Dec 31, 2019 | $5.12M | Mar 10, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.28B | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $3.60B | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $3.83B | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $3.55B | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $2.97B | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $2.82B | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $2.91B | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $2.67B | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $1.94B | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $1.71B | Mar 6, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.98B | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $3.28B | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $3.52B | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $3.25B | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $2.69B | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $2.57B | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $2.67B | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $2.47B | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $1.77B | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $1.58B | Mar 6, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $304.28M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $323.93M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $314.06M | Mar 9, 2026 |
| FY2025 | Dec 31, 2022 | $291.25M | Mar 9, 2026 |
| FY2024 | Dec 31, 2021 | $274.02M | Mar 7, 2025 |
| FY2023 | Dec 31, 2020 | $249.21M | Mar 8, 2024 |
| FY2021 | Dec 31, 2019 | $239.47M | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | $200.22M | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $176.45M | Mar 11, 2020 |
| FY2018 | Dec 31, 2016 | $131.08M | Mar 18, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Mar 8, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 10, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 10, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 10, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 10, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 10, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Mar 8, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 10, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 10, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 10, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 10, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 10, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $195.26M | Mar 18, 2019 |
| FY2018 | Dec 31, 2017 | $124.24M | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | $65.04M | Mar 18, 2019 |
| FY2018 | Dec 31, 2015 | $132.64M | Mar 18, 2019 |
| FY2017 | Dec 31, 2014 | $32.12M | Mar 6, 2018 |
| FY2016 | Dec 31, 2013 | $29.84M | Mar 13, 2017 |
| FY2015 | Dec 31, 2012 | $34.15M | Mar 14, 2016 |
| FY2014 | Dec 31, 2011 | $116.10M | Mar 12, 2015 |
| FY2013 | Dec 31, 2010 | $121.13M | Mar 17, 2014 |
| FY2012 | Dec 31, 2009 | $67.35M | Mar 18, 2013 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $133.00M | Mar 12, 2015 |
| FY2014 | Dec 31, 2013 | $110.00M | Mar 12, 2015 |
| FY2013 | Dec 31, 2012 | $110.00M | Mar 17, 2014 |
| FY2012 | Dec 31, 2011 | $129.53M | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | $114.12M | Mar 30, 2012 |